Cowen Inc’s Vanda Pharmaceuticals VNDA Stock Holding History

Cowen Inc’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-52,100	Closed	-$1K	–	446
2014 Q4	$1K	Buy	+52,100	New	+$616K	﹤0.01%	220

Other funds holding VNDA

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cowen Inc's VNDA Position: Q3 2015 in Review

Cowen Inc sold out of Vanda Pharmaceuticals (VNDA) in Q3 2015, closing a stake of 19,725 shares — an estimated $250K sold.

Cowen Inc first reported a position in VNDA in Q4 2013 and held it in 7 quarters. The position peaked at $488K in Q1 2014. 122 funds tracked by Wall St. Rank hold VNDA as of Q3 2015.

Cowen Inc reported no remaining Vanda Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Cowen Inc sold 19,725 Vanda Pharmaceuticals shares in Q3 2015, an estimated $250K.
Cowen Inc first reported a position in Vanda Pharmaceuticals in Q4 2013 and held it in 7 quarters.
Cowen Inc's Vanda Pharmaceuticals position peaked at $488K in Q1 2014.
122 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.